Thomas Hope, MD, Author at Grand Rounds in Urology

Thomas Hope, MD

University of California, San Francisco

San Francisco, California

Thomas Hope, MD, is an Assistant Professor in Abdominal Imaging and Nuclear Medicine in the Department of Radiology at the University of California, San Francisco. He received his MD from Stanford University and completed an internship at Kaiser Permanente, a residency in Diagnostic Radiology at UCSF, and a Clinical Fellowship in Body MRI and Nuclear Medicine at Stanford. He is the Director for Molecular Therapy. Dr. Hope is the PI on the Ga-68 PSMA-11 IND, has helped lead the development of the clinical PET/MRI program, and is developing the program for neuroendocrine tumors at UCSF. He has published 100+ peer-reviewed articles and is a member of the Radiological Society of North America, the Society of Nuclear Medicine and Molecular Imaging, and the International Society for Magnetic Resonance in Medicine.

Disclosures:

Talks by Thomas Hope, MD

Appropriate Use of PSMA PET in Clinical Practice

Posted by Thomas Hope, MD | Nov 2022

In this 10-minute video, Thomas Hope, MD, Assistant Professor in Abdominal Imaging and Nuclear Medicine in the Department of Radiology at the University of California, San Francisco, discusses the appropriate use criteria (AUC) of PSMA PET in clinical practice. He summarizes the guidelines for the appropriate use of PSMA PET and delves into the studies that inform them.

PSMA-11 PET: Atypical Paths to FDA Approval and Academic NDAs

Posted by Thomas Hope, MD | Feb 2020

Thomas Hope, MD, Assistant Professor in Residence in Abdominal Imaging and Nuclear Medicine in the Department of Radiology at the University of California, San Francisco, explains how an academic institution successfully submits a new drug application (NDA) to the US Food and Drug Administration (FDA), using the NDA for prostate-specific membrane antigen (PSMA) 11 as an example. He notes the limitations that academia has in this area, and recommends that, going forward, institutions design imaging studies so that they report usable detection rates and have blinded readers.